What is a non-invasive method recommended for localized control measures during surgery with patients with low platelet counts?

Microfibrillar collagen is recognized as a non-invasive method for achieving localized hemostasis, particularly beneficial in surgical settings involving patients with low platelet counts. It functions by providing a scaffold that facilitates platelet aggregation and acts as a matrix for clot formation, helping to control bleeding effectively without requiring invasive techniques such as suturing or additional invasive measures.

The efficacy of microfibrillar collagen in promoting hemostasis becomes particularly valuable in patients with thrombocytopenia since these patients may not achieve the necessary clotting response through conventional methods, which often rely heavily on platelet function. This method's non-invasive nature allows for its application directly at the bleeding site, minimizing trauma and promoting healing during surgery.

In contrast, while sutures can also be used to control bleeding, they are more invasive and can potentially cause additional tissue trauma in patients who may already be compromised. Pressure packs and topical thrombin also provide hemostatic assistance but may not be as specific or effective in scenarios with severely low platelet levels, making microfibrillar collagen the preferred choice for localized control in this context.